Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 10.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of ... Read More
-
Global Electronic Drug Delivery Systems Market Size study & Forecast, by Type (Wearable Infusion Pumps, Autoinjectors, Injection Pens and Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD and Other Indications) and Regional Analysis, 2022-2029
... Analysis, 2022-2029 Global Electronic Drug Delivery Systems Market is valued approximately USD 9.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. ... Read More
-
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... UK, Japan) and provides an Excel-based forecast model for the diabetic neuropathic pain market through 2031. Diabetic neuropathic pain (DNP) is clinically defined as pain resulting from peripheral, autonomic, focal, or proximal nerve damage in ... Read More
-
2023 Global: Blood Glucose Monitoring System Market - Innovative Markets Forecast (2029) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Europe Diabetic Foot Ulcers Market - 2023-2030
... a CAGR of XX% during the forecast period (2023-2030). A diabetic foot ulcer is a familiar condition in diabetic patients and is a critical health regard worldwide. Diabetic foot ulcers are thickened wounds below the ... Read More
-
Global Microkeratome Market Size, Trends & Growth Opportunity, By Product (Disposable, and Reusable), By Technology (Fully Invasive, and Minimally Invasive), By Treatment (Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
... & Forecast, 2022 – 2027. Global Microkeratome Market Global Microkeratome Market was valued at USD 878.90 million in 2022 and is slated to reach at USD 1340.26 million by 2027 at a CAGR of 9.2% ... Read More
-
Global Microkeratome Market Size, Trends & Growth Opportunity, By Product (Disposable, and Reusable), By Technology (Fully Invasive, and Minimally Invasive), By Treatment (Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, and Others), By Region and Forecast till 2027
... 2027 Global Microkeratome Market Global Microkeratome Market was valued at USD 878.90 million in 2022 and is slated to reach at USD 1340.26 million by 2027 at a CAGR of 9.2% from 2022-2027. Microkeratome is ... Read More
-
Global Biosimilars Insulin Market Growth 2023-2029
... and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference insulin product and is already been approved by FDA or licensed. The producers of biosimilars use the similar manufacturing ... Read More
-
Global Stem Cell Therapy for Diabetes and Related Conditions Market Growth (Status and Outlook) 2023-2029
... two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). LPI (LP Information)' newest research report, the “Stem Cell Therapy for Diabetes and Related Conditions Industry ... Read More
-
Global Lifestyle Diseases Apps Market Size study & Forecast, by Platform Type (iOS, Android, Others), by Device (Smartphones, Tablets, Wearables), by Indication (Obesity, Cardiovascular Health, Mental Health, Diabetes, Others) and Regional Analysis, 2022-2029
... Diseases Apps Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.7% over the forecast period 2022-2029. Lifestyle diseases apps are ... Read More
-
Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027
... global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as ... Read More
-
Enteral Feeding Devices Market by Type (Feeding Tube (Gastrostomy, Jejunostomy), Feeding Pump, Giving Set), Age Group (Adult, Pediatric), Application (Diabetes, Neurological Disorder, Cancer), End User (Hospital, ACS, Home Care) - Global Forecast to 2027
... global enteral feeding devices market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, growing at a CAGR of 6.9% during the forecast period. Rapid growth in geriatric population ... Read More
-
Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 68.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.48% during 2023-2028. Human insulin (HI) is a short-acting form of insulin used to treat hyperglycemia caused by type 1 and type 2 diabetes. It ... Read More
-
Diabetes Injection Pen Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Diabetes Injection Pen market report analyzes the Diabetes Injection Pen market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031
... decreased blood flow and high blood sugar levels (Sadosky et al., 2008). Diabetic neuropathy refers to a variety of syndromes that differ in clinical course, distribution, and fiber involvement. PDN occurs in diabetic patients that ... Read More
-
UAE Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027
... Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027 UAE human insulin market is anticipated to register growth with ... Read More
-
UAE Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets} v/s Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition Forecast & Opportunities, 2027
... Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition Forecast & Opportunities, 2027 UAE blood glucose monitoring devices market is anticipated to register growth with an impressive CAGR ... Read More
-
Continuous Glucose Monitoring Systems Market Intelligence Report - Global Forecast 2023-2030
... CAGR 12.31% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to ... Read More
-
France Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis
... to 2028, according to Renub Research. In recent years, France has witnessed an alarming increase in the prevalence of diabetes. Diabetes has the highest prevalence among all chronic conditions. France's statutory health insurance (SHI) covers ... Read More
-
2023 Global Blood Glucose Monitoring System Market Industry (2029 Outlook)
... data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and ... Read More
-
2023 Global Blood Glucose Test Strips Market Industry (2029 Outlook)
... data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and ... Read More
-
Fill Finish Catridge Market: Current Analysis and Forecast (2022-2028)
... of the product. The market for fill finish cartridges is growing at a tremendous rate owing to the rising number of pharmaceutical companies and the surge in the demand for biologics drugs in the management ... Read More
-
UAE Clinical Nutrition Market By Nutrition Type (Enteral Nutrition {Oral Nutrition Supplements v/s Tube Feeding} v/s Parental Nutrition {Supplemental Parenteral Nutrition, Total Parenteral Nutrition; All-in-one System, Multiple Bottle System}), By Route of Administration (Oral v/s Intravenous), By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary Fiber, Antioxidants), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Region, Competition Forecast & Opportunities, 2027
... Intravenous), By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary Fiber, Antioxidants), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, ... Read More
-
Israel Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis
... of the adult population of Israel, making it one of the highest rates in the world. Diabetes is a chronic disease marked by excessive amounts of glucose (sugar) in the blood, which can lead to ... Read More
Research Assistance
